Kevin Bruce Johnson Talaris Therapeutics, Inc. (TALS) insider trading activity
Kevin Bruce Johnson is Chief Regulatory Officer of Talaris Therapeutics, Inc.. Currently has a direct ownership of 57,834 shares of TALS, which is worth approximately $157,308. The most recent transaction as insider was on Oct 19, 2023, when has been sold 57,834 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
57.8K
0%
3M change
0%
12M change
Total Value Held
$157,308
KBJ
Kevin Bruce Johnson
Chief Regulatory Officer
New York, NY